25 XP   0   0   10

Novavax Inc
Buy, Hold or Sell?

Let's analyse Novavax together

PenkeI guess you are interested in Novavax Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Novavax Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Novavax Inc

I send you an email if I find something interesting about Novavax Inc.

Quick analysis of Novavax (30 sec.)










What can you expect buying and holding a share of Novavax? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$-5.12
Expected worth in 1 year
$-5.71
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$-0.59
Return On Investment
-15.2%

For what price can you sell your share?

Current Price per Share
$3.89
Expected price per share
$3.5324 - $6.05
How sure are you?
50%

1. Valuation of Novavax (5 min.)




Live pricePrice per Share (EOD)

$3.89

Intrinsic Value Per Share

$-35.44 - $-18.90

Total Value Per Share

$-40.56 - $-24.03

2. Growth of Novavax (5 min.)




Is Novavax growing?

Current yearPrevious yearGrowGrow %
How rich?-$716.9m-$387.9m-$373.4m-49.0%

How much money is Novavax making?

Current yearPrevious yearGrowGrow %
Making money-$136.2m-$164.4m$28.2m20.7%
Net Profit Margin-250.8%-83.0%--

How much money comes from the company's main activities?

3. Financial Health of Novavax (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#1014 / 1016

Most Revenue
#69 / 1016

Most Profit
#998 / 1016

Most Efficient
#664 / 1016

What can you expect buying and holding a share of Novavax? (5 min.)

Welcome investor! Novavax's management wants to use your money to grow the business. In return you get a share of Novavax.

What can you expect buying and holding a share of Novavax?

First you should know what it really means to hold a share of Novavax. And how you can make/lose money.

Speculation

The Price per Share of Novavax is $3.89. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Novavax.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Novavax, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-5.12. Based on the TTM, the Book Value Change Per Share is $-0.15 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.50 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Novavax.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.27-32.8%-0.35-8.9%-1.18-30.2%-1.12-28.9%-0.72-18.5%
Usd Book Value Change Per Share-0.28-7.1%-0.15-3.8%-0.50-13.0%-0.20-5.0%-0.16-4.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.1%0.000.0%0.000.0%
Usd Total Gains Per Share-0.28-7.1%-0.15-3.8%-0.50-12.9%-0.20-5.0%-0.16-4.2%
Usd Price Per Share4.80-6.60-38.39-62.81-33.45-
Price to Earnings Ratio-0.94-1.45-0.85--15.73--10.19-
Price-to-Total Gains Ratio-17.41--0.11--7.16--16.35--13.58-
Price to Book Ratio-0.94--1.22-33.44-16.94-8.24-
Price-to-Total Gains Ratio-17.41--0.11--7.16--16.35--13.58-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.89
Number of shares257
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.15-0.20
Usd Total Gains Per Share-0.15-0.20
Gains per Quarter (257 shares)-38.03-50.23
Gains per Year (257 shares)-152.14-200.90
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-152-1621-202-211
20-304-3141-403-412
30-456-4662-605-613
40-609-6183-807-814
50-761-7704-1008-1015
60-913-9224-1210-1216
70-1065-10745-1411-1417
80-1217-12266-1613-1618
90-1369-13786-1815-1819
100-1521-15307-2016-2020

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%3.09.00.025.0%3.017.00.015.0%3.037.00.07.5%4.0108.00.03.6%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%9.011.00.045.0%13.027.00.032.5%38.073.01.033.9%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%1.00.039.02.5%1.00.0111.00.9%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%9.011.00.045.0%13.027.00.032.5%38.073.01.033.9%

Fundamentals of Novavax

About Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Fundamental data was last updated by Penke on 2024-04-10 22:40:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Novavax Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Novavax earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Novavax to the Biotechnology industry mean.
  • A Net Profit Margin of -61.2% means that $-0.61 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Novavax Inc:

  • The MRQ is -61.2%. The company is making a huge loss. -2
  • The TTM is -250.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-61.2%TTM-250.8%+189.6%
TTM-250.8%YOY-83.0%-167.8%
TTM-250.8%5Y-320.7%+69.9%
5Y-320.7%10Y-565.3%+244.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-61.2%-197.2%+136.0%
TTM-250.8%-210.4%-40.4%
YOY-83.0%-279.3%+196.3%
5Y-320.7%-436.8%+116.1%
10Y-565.3%-599.3%+34.0%
1.1.2. Return on Assets

Shows how efficient Novavax is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Novavax to the Biotechnology industry mean.
  • -9.6% Return on Assets means that Novavax generated $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Novavax Inc:

  • The MRQ is -9.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.6%TTM-8.3%-1.3%
TTM-8.3%YOY-6.9%-1.3%
TTM-8.3%5Y-12.0%+3.7%
5Y-12.0%10Y-12.4%+0.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.6%-13.6%+4.0%
TTM-8.3%-12.9%+4.6%
YOY-6.9%-11.9%+5.0%
5Y-12.0%-14.2%+2.2%
10Y-12.4%-16.2%+3.8%
1.1.3. Return on Equity

Shows how efficient Novavax is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Novavax to the Biotechnology industry mean.
  • 0.0% Return on Equity means Novavax generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Novavax Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY77.8%-77.8%
TTM-5Y-2.5%+2.5%
5Y-2.5%10Y-9.5%+7.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--17.0%+17.0%
TTM--16.1%+16.1%
YOY77.8%-15.4%+93.2%
5Y-2.5%-20.0%+17.5%
10Y-9.5%-21.1%+11.6%

1.2. Operating Efficiency of Novavax Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Novavax is operating .

  • Measures how much profit Novavax makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Novavax to the Biotechnology industry mean.
  • An Operating Margin of -63.0% means the company generated $-0.63  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Novavax Inc:

  • The MRQ is -63.0%. The company is operating very inefficient. -2
  • The TTM is -254.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-63.0%TTM-254.5%+191.5%
TTM-254.5%YOY-83.0%-171.5%
TTM-254.5%5Y-339.6%+85.1%
5Y-339.6%10Y-565.2%+225.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-63.0%-286.1%+223.1%
TTM-254.5%-224.4%-30.1%
YOY-83.0%-288.4%+205.4%
5Y-339.6%-475.2%+135.6%
10Y-565.2%-624.7%+59.5%
1.2.2. Operating Ratio

Measures how efficient Novavax is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.63 means that the operating costs are $1.63 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Novavax Inc:

  • The MRQ is 1.630. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.244. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.630TTM3.244-1.614
TTM3.244YOY1.830+1.414
TTM3.2445Y5.554-2.310
5Y5.55410Y10.327-4.773
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6302.997-1.367
TTM3.2443.247-0.003
YOY1.8303.766-1.936
5Y5.5545.675-0.121
10Y10.3277.857+2.470

1.3. Liquidity of Novavax Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Novavax is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.70 means the company has $0.70 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Novavax Inc:

  • The MRQ is 0.700. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.649. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.700TTM0.649+0.050
TTM0.649YOY0.944-0.295
TTM0.6495Y2.469-1.820
5Y2.46910Y4.364-1.895
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7003.930-3.230
TTM0.6494.251-3.602
YOY0.9445.436-4.492
5Y2.4696.045-3.576
10Y4.3646.363-1.999
1.3.2. Quick Ratio

Measures if Novavax is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Novavax to the Biotechnology industry mean.
  • A Quick Ratio of 0.54 means the company can pay off $0.54 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Novavax Inc:

  • The MRQ is 0.536. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.503. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.536TTM0.503+0.033
TTM0.503YOY0.762-0.258
TTM0.5035Y2.339-1.836
5Y2.33910Y4.995-2.657
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5363.629-3.093
TTM0.5034.065-3.562
YOY0.7625.397-4.635
5Y2.3395.993-3.654
10Y4.9956.277-1.282

1.4. Solvency of Novavax Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Novavax assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Novavax to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.39 means that Novavax assets are financed with 138.6% credit (debt) and the remaining percentage (100% - 138.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Novavax Inc:

  • The MRQ is 1.386. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.456. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.386TTM1.456-0.070
TTM1.456YOY1.167+0.289
TTM1.4565Y1.252+0.204
5Y1.25210Y1.005+0.246
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3860.332+1.054
TTM1.4560.334+1.122
YOY1.1670.268+0.899
5Y1.2520.366+0.886
10Y1.0050.390+0.615
1.4.2. Debt to Equity Ratio

Measures if Novavax is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Novavax to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Novavax Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY10.599-10.599
TTM-5Y3.230-3.230
5Y3.23010Y2.000+1.230
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.381-0.381
TTM-0.390-0.390
YOY10.5990.334+10.265
5Y3.2300.434+2.796
10Y2.0000.466+1.534

2. Market Valuation of Novavax Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Novavax generates.

  • Above 15 is considered overpriced but always compare Novavax to the Biotechnology industry mean.
  • A PE ratio of -0.94 means the investor is paying $-0.94 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Novavax Inc:

  • The EOD is -0.763. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.941. Based on the earnings, the company is expensive. -2
  • The TTM is 1.446. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-0.763MRQ-0.941+0.178
MRQ-0.941TTM1.446-2.387
TTM1.446YOY0.848+0.597
TTM1.4465Y-15.727+17.173
5Y-15.72710Y-10.187-5.540
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.763-2.315+1.552
MRQ-0.941-2.560+1.619
TTM1.446-2.664+4.110
YOY0.848-4.122+4.970
5Y-15.727-6.258-9.469
10Y-10.187-6.108-4.079
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Novavax Inc:

  • The EOD is -0.732. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.904. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.852. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.732MRQ-0.904+0.171
MRQ-0.904TTM-1.852+0.949
TTM-1.852YOY-11.393+9.541
TTM-1.8525Y-16.564+14.712
5Y-16.56410Y-10.792-5.772
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.732-3.067+2.335
MRQ-0.904-3.251+2.347
TTM-1.852-3.545+1.693
YOY-11.393-5.595-5.798
5Y-16.564-8.315-8.249
10Y-10.792-8.708-2.084
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Novavax is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.94 means the investor is paying $-0.94 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Novavax Inc:

  • The EOD is -0.759. Based on the equity, the company is expensive. -2
  • The MRQ is -0.937. Based on the equity, the company is expensive. -2
  • The TTM is -1.223. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.759MRQ-0.937+0.178
MRQ-0.937TTM-1.223+0.286
TTM-1.223YOY33.440-34.663
TTM-1.2235Y16.937-18.160
5Y16.93710Y8.239+8.698
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.7591.905-2.664
MRQ-0.9372.111-3.048
TTM-1.2232.095-3.318
YOY33.4402.836+30.604
5Y16.9373.443+13.494
10Y8.2393.794+4.445
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Novavax Inc.

3.1. Institutions holding Novavax Inc

Institutions are holding 56.321% of the shares of Novavax Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31State Street Corporation11.98680.003916775875660125864.8797
2023-12-31Vanguard Group Inc10.40350.001514560061300858526.045
2023-12-31BlackRock Inc6.02790.0018436179136929819.3763
2023-12-31Shah Capital Management5.55959.56687780756145000022.9041
2023-12-31Morgan Stanley - Brokerage Accounts5.17420.003172414554966324218.2874
2023-12-31Geode Capital Management, LLC1.64160.0012229750743653023.457
2023-12-31Goldman Sachs Group Inc1.23430.000717274681161621205.2889
2023-12-31Rafferty Asset Management, LLC1.15170.0326161184061937062.4069
2023-12-31Coatue Management LLC1.08580.0306151959415195940
2023-12-31Bank of America Corp0.94810.0006132694220840318.6317
2023-12-31Citigroup Inc0.8530.0041193757-371196-23.7193
2023-12-31TSP Capital Management Group/LLC0.79431.8488111170014535015.0411
2023-12-31JANE STREET GROUP, LLC0.78350.00141096505709291183.178
2023-12-31Northern Trust Corp0.71620.0009100235913657615.7749
2023-12-31BNP Paribas Arbitrage, SA0.61550.004786147927838147.7417
2023-12-31Bank of Montreal0.61150.0028557578557570
2023-12-31BMO Capital Markets Corp.0.61150.0028557578557570
2023-12-31Barclays PLC0.58710.001582167626788648.3732
2023-12-31Charles Schwab Investment Management Inc0.54330.0009760333569838.1017
2023-12-31Allianz Asset Management AG0.45350.00563469219977145.9327
Total 51.782811.513272471692+24475539+33.8%

3.2. Funds holding Novavax Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-28SPDR® S&P Biotech ETF10.01690.8874140189881768401.2775
2024-02-29Vanguard Total Stock Mkt Idx Inv2.53170.00113543236-273300-7.1609
2024-02-29Vanguard Small Cap Index2.07780.01022907981268090.9305
2024-03-28iShares Russell 2000 ETF1.99130.0203278694613440.0482
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.30730.0089182962211730.0642
2024-03-31Direxion Daily S&P Biotech Bull 3X ETF1.20230.6441682659-11805-0.6967
2024-02-29Vanguard Small Cap Growth Index Inv1.16630.02311632279271431.691
2023-12-31Vanguard Strategic Equity Inv1.10230.0951154266420988215.7477
2024-03-28iShares Biotechnology ETF0.70940.062299279614920217.6865
2023-12-31Vanguard Explorer Inv0.69480.021897237110498812.104
2024-01-31Fidelity Small Cap Index0.6870.0155961495117381.2359
2024-03-28iShares Russell 2000 Growth ETF0.57490.033804579-936-0.1162
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.4070.006756962547000.832
2023-12-31PIMCO RAE US Small Instl0.4020.331556259816675442.1262
2024-03-29Schwab US Small-Cap ETF™0.39950.015655916800
2024-02-29Vanguard Health Care ETF0.26060.00863647825756618.738
2024-02-29Vanguard Russell 2000 ETF0.24730.0179346155270568.4789
2023-12-31Vanguard Market Neutral I0.24660.3358345121-29187-7.7976
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.22930.015732090000
2023-12-31Vanguard Strategic Small-Cap Equity Inv0.21420.09662997799620147.2551
Total 26.46852.65137043744+746168+2.0%

3.3. Insider Transactions

Insiders are holding 4.99% of the shares of Novavax Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-03-10Gregory M GlennBUY10006.5
2023-03-06Gregory M GlennBUY30007.48
2022-03-31James F YoungSELL1250073.58
2022-01-03John A Herrmann IiiSELL5000140.91
2021-12-20John A Herrmann IiiSELL5000230
2021-12-15Gregory M GlennSELL1686174.13
2021-12-07Gregory M GlennSELL8250170.14
2021-12-01John A Herrmann IiiSELL5000196.19
2021-11-30Gregory M GlennSELL8942203.2
2021-11-29John A Herrmann IiiSELL5000228.72
2021-11-26Gregory M GlennSELL2083218.07
2021-11-23Gregory M GlennSELL8250199.5
2021-11-09Gregory M GlennSELL8250167.53
2021-11-03John A Herrmann IiiSELL5000200
2021-11-02Gregory M GlennSELL8250183.82
2021-11-01John A Herrmann IiiSELL5000163.08
2021-10-29Gregory M GlennSELL680148.34
2021-10-26Gregory M GlennSELL10334132.73
2021-10-19Gregory M GlennSELL8250165.14
2021-10-15Gregory M GlennSELL1183170

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Novavax Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.276-0.148-46%-0.504+83%-0.196-29%-0.164-40%
Book Value Per Share---5.123-5.440+6%-2.772-46%-0.900-82%-0.092-98%
Current Ratio--0.7000.649+8%0.944-26%2.469-72%4.364-84%
Debt To Asset Ratio--1.3861.456-5%1.167+19%1.252+11%1.005+38%
Debt To Equity Ratio----0%10.599-100%3.230-100%2.000-100%
Dividend Per Share----0%0.004-100%0.001-100%0.000-100%
Eps---1.275-0.345-73%-1.175-8%-1.124-12%-0.721-43%
Free Cash Flow Per Share---1.328-1.380+4%-0.909-32%-0.447-66%-0.370-72%
Free Cash Flow To Equity Per Share---0.611-1.372+125%-0.329-46%0.222-375%0.101-705%
Gross Profit Margin--1.0001.0000%1.227-18%1.045-4%1.023-2%
Intrinsic Value_10Y_max---18.904--------
Intrinsic Value_10Y_min---35.438--------
Intrinsic Value_1Y_max---1.543--------
Intrinsic Value_1Y_min---2.629--------
Intrinsic Value_3Y_max---4.905--------
Intrinsic Value_3Y_min---8.745--------
Intrinsic Value_5Y_max---8.588--------
Intrinsic Value_5Y_min---15.741--------
Market Cap544417138.880-23%671774361.600923689747.200-27%5372795362.880-87%8790173819.421-92%4681500707.838-86%
Net Profit Margin---0.612-2.508+310%-0.830+36%-3.207+424%-5.653+823%
Operating Margin---0.630-2.545+304%-0.830+32%-3.396+439%-5.652+797%
Operating Ratio--1.6303.244-50%1.830-11%5.554-71%10.327-84%
Pb Ratio-0.759+19%-0.937-1.223+31%33.440-103%16.937-106%8.239-111%
Pe Ratio-0.763+19%-0.9411.446-165%0.848-211%-15.727+1570%-10.187+982%
Price Per Share3.890-23%4.8006.600-27%38.390-87%62.808-92%33.451-86%
Price To Free Cash Flow Ratio-0.732+19%-0.904-1.852+105%-11.393+1161%-16.564+1733%-10.792+1094%
Price To Total Gains Ratio-14.112+19%-17.414-0.112-99%-7.164-59%-16.347-6%-13.584-22%
Quick Ratio--0.5360.503+7%0.762-30%2.339-77%4.995-89%
Return On Assets---0.096-0.083-14%-0.069-28%-0.120+24%-0.124+29%
Return On Equity----0%0.778-100%-0.0250%-0.0950%
Total Gains Per Share---0.276-0.148-46%-0.501+82%-0.195-29%-0.164-40%
Usd Book Value---716927000.000-761344500.000+6%-387922250.000-46%-126022100.000-82%-12883375.000-98%
Usd Book Value Change Per Share---0.276-0.148-46%-0.504+83%-0.196-29%-0.164-40%
Usd Book Value Per Share---5.123-5.440+6%-2.772-46%-0.900-82%-0.092-98%
Usd Dividend Per Share----0%0.004-100%0.001-100%0.000-100%
Usd Eps---1.275-0.345-73%-1.175-8%-1.124-12%-0.721-43%
Usd Free Cash Flow---185859000.000-193193250.000+4%-127230500.000-32%-62593900.000-66%-51832450.000-72%
Usd Free Cash Flow Per Share---1.328-1.380+4%-0.909-32%-0.447-66%-0.370-72%
Usd Free Cash Flow To Equity Per Share---0.611-1.372+125%-0.329-46%0.222-375%0.101-705%
Usd Market Cap544417138.880-23%671774361.600923689747.200-27%5372795362.880-87%8790173819.421-92%4681500707.838-86%
Usd Price Per Share3.890-23%4.8006.600-27%38.390-87%62.808-92%33.451-86%
Usd Profit---178389000.000-136265500.000-24%-164484750.000-8%-174885250.000-2%-109651800.000-39%
Usd Revenue--291342000.000204695750.000+42%478074750.000-39%218581600.000+33%112983975.000+158%
Usd Total Gains Per Share---0.276-0.148-46%-0.501+82%-0.195-29%-0.164-40%
 EOD+2 -6MRQTTM+17 -14YOY+11 -255Y+8 -2710Y+8 -27

4.2. Fundamental Score

Let's check the fundamental score of Novavax Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.763
Price to Book Ratio (EOD)Between0-1-0.759
Net Profit Margin (MRQ)Greater than0-0.612
Operating Margin (MRQ)Greater than0-0.630
Quick Ratio (MRQ)Greater than10.536
Current Ratio (MRQ)Greater than10.700
Debt to Asset Ratio (MRQ)Less than11.386
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.096
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of Novavax Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.153
Ma 20Greater thanMa 504.437
Ma 50Greater thanMa 1004.677
Ma 100Greater thanMa 2004.768
OpenGreater thanClose3.890
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -6,3773,211-3,166-5,011-8,177-3,686-11,86314,5852,722



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,855,342
Total Liabilities2,572,269
Total Stockholder Equity-716,927
 As reported
Total Liabilities 2,572,269
Total Stockholder Equity+ -716,927
Total Assets = 1,855,342

Assets

Total Assets1,855,342
Total Current Assets1,143,888
Long-term Assets711,454
Total Current Assets
Cash And Cash Equivalents 578,929
Net Receivables 297,240
Inventory 41,696
Other Current Assets 226,023
Total Current Assets  (as reported)1,143,888
Total Current Assets  (calculated)1,143,888
+/-0
Long-term Assets
Property Plant Equipment 490,989
Goodwill 127,454
Long-term Assets Other 30,278
Long-term Assets  (as reported)711,454
Long-term Assets  (calculated)648,721
+/- 62,733

Liabilities & Shareholders' Equity

Total Current Liabilities1,635,138
Long-term Liabilities937,131
Total Stockholder Equity-716,927
Total Current Liabilities
Short-term Debt 28,119
Accounts payable 132,610
Other Current Liabilities 1,233,099
Total Current Liabilities  (as reported)1,635,138
Total Current Liabilities  (calculated)1,393,828
+/- 241,310
Long-term Liabilities
Long term Debt 168,016
Capital Lease Obligations 61,065
Long-term Liabilities Other 33,130
Long-term Liabilities  (as reported)937,131
Long-term Liabilities  (calculated)262,211
+/- 674,920
Total Stockholder Equity
Common Stock1,405
Retained Earnings -4,820,951
Accumulated Other Comprehensive Income 2,722
Other Stockholders Equity 4,099,897
Total Stockholder Equity (as reported)-716,927
Total Stockholder Equity (calculated)-716,927
+/-0
Other
Capital Stock1,405
Cash and Short Term Investments 578,929
Common Stock Shares Outstanding 123,679
Current Deferred Revenue241,310
Liabilities and Stockholders Equity 1,855,342
Net Debt -298,294
Net Invested Capital -548,911
Net Working Capital -491,250
Property Plant and Equipment Gross 565,957
Short Long Term Debt Total 280,635



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-31
> Total Assets 
6,800
6,000
5,300
5,700
9,500
8,600
7,400
6,800
12,100
11,100
10,000
3,800
3,800
5,500
4,500
4,500
18,878
16,638
14,487
56,529
54,332
57,381
68,830
67,115
62,890
70,049
62,228
57,505
68,037
63,908
61,563
84,159
78,800
74,617
87,600
77,993
66,578
60,298
60,546
84,382
135,432
130,576
125,381
121,877
115,390
108,039
99,706
91,291
86,221
80,777
89,519
76,625
67,962
73,221
75,880
85,605
75,377
68,945
79,314
74,844
70,136
69,346
67,085
66,576
68,637
76,977
80,546
102,345
98,704
92,918
245,074
235,937
218,599
311,991
292,514
276,002
438,841
424,698
404,634
386,038
592,507
525,004
459,626
394,301
361,504
355,706
334,077
302,493
276,067
285,807
250,478
207,978
221,319
189,389
164,810
172,957
328,068
932,227
944,020
1,582,479
2,608,366
2,749,587
2,565,941
2,576,753
2,834,875
2,622,993
2,267,437
2,258,679
1,542,699
1,685,048
1,657,157
1,855,342
1,855,3421,657,1571,685,0481,542,6992,258,6792,267,4372,622,9932,834,8752,576,7532,565,9412,749,5872,608,3661,582,479944,020932,227328,068172,957164,810189,389221,319207,978250,478285,807276,067302,493334,077355,706361,504394,301459,626525,004592,507386,038404,634424,698438,841276,002292,514311,991218,599235,937245,07492,91898,704102,34580,54676,97768,63766,57667,08569,34670,13674,84479,31468,94575,37785,60575,88073,22167,96276,62589,51980,77786,22191,29199,706108,039115,390121,877125,381130,576135,43284,38260,54660,29866,57877,99387,60074,61778,80084,15961,56363,90868,03757,50562,22870,04962,89067,11568,83057,38154,33256,52914,48716,63818,8784,5004,5005,5003,8003,80010,00011,10012,1006,8007,4008,6009,5005,7005,3006,0006,800
   > Total Current Assets 
3,900
3,100
2,300
3,200
6,900
6,000
4,900
4,300
9,500
8,500
7,400
1,200
1,200
3,000
1,100
1,100
15,518
12,996
10,706
17,036
11,960
15,594
27,771
25,027
17,352
21,762
11,989
6,242
16,759
12,837
10,247
32,062
26,620
22,577
32,460
23,937
13,573
8,304
10,704
37,611
89,450
84,489
80,100
77,342
71,066
63,480
55,317
49,016
43,036
38,309
46,681
35,096
26,642
32,041
34,935
44,503
33,817
27,594
37,810
33,337
28,976
28,416
26,253
26,109
26,442
34,978
36,484
50,408
51,722
45,365
155,020
145,001
128,873
166,602
191,979
188,158
350,094
332,979
310,102
287,257
484,595
419,981
353,905
287,830
258,449
236,683
225,995
203,311
181,034
194,335
160,541
119,276
123,394
110,218
89,022
97,247
255,232
636,381
671,217
1,248,203
2,246,784
2,354,992
2,174,181
2,155,119
2,347,405
2,136,002
1,759,965
1,703,391
971,028
1,127,554
1,006,764
1,143,888
1,143,8881,006,7641,127,554971,0281,703,3911,759,9652,136,0022,347,4052,155,1192,174,1812,354,9922,246,7841,248,203671,217636,381255,23297,24789,022110,218123,394119,276160,541194,335181,034203,311225,995236,683258,449287,830353,905419,981484,595287,257310,102332,979350,094188,158191,979166,602128,873145,001155,02045,36551,72250,40836,48434,97826,44226,10926,25328,41628,97633,33737,81027,59433,81744,50334,93532,04126,64235,09646,68138,30943,03649,01655,31763,48071,06677,34280,10084,48989,45037,61110,7048,30413,57323,93732,46022,57726,62032,06210,24712,83716,7596,24211,98921,76217,35225,02727,77115,59411,96017,03610,70612,99615,5181,1001,1003,0001,2001,2007,4008,5009,5004,3004,9006,0006,9003,2002,3003,1003,900
       Cash And Cash Equivalents 
3,900
3,000
2,100
2,500
6,800
5,800
4,800
3,800
9,200
8,300
7,200
1,000
1,000
2,800
1,000
700
14,693
12,285
10,059
14,864
8,893
11,437
23,296
20,045
10,885
15,927
7,630
3,005
14,320
9,625
6,045
27,633
21,885
15,623
27,503
17,876
9,202
4,442
6,944
31,893
83,941
78,601
21,294
7,161
7,782
7,337
15,816
4,350
14,702
23,513
36,794
26,938
19,629
25,216
29,984
38,757
14,575
9,446
16,215
8,061
8,358
13,092
14,318
14,104
13,873
15,334
10,738
17,399
9,023
2,574
122,493
119,471
109,921
103,857
34,473
32,335
215,050
167,384
138,144
93,108
132,225
89,395
119,948
144,353
95,847
75,793
104,245
106,307
113,402
88,475
56,496
70,154
97,711
71,995
71,167
78,823
179,881
424,395
334,171
553,398
1,995,482
2,074,880
1,936,998
1,515,116
1,570,954
1,375,587
1,280,581
1,336,883
624,950
505,912
651,104
578,929
578,929651,104505,912624,9501,336,8831,280,5811,375,5871,570,9541,515,1161,936,9982,074,8801,995,482553,398334,171424,395179,88178,82371,16771,99597,71170,15456,49688,475113,402106,307104,24575,79395,847144,353119,94889,395132,22593,108138,144167,384215,05032,33534,473103,857109,921119,471122,4932,5749,02317,39910,73815,33413,87314,10414,31813,0928,3588,06116,2159,44614,57538,75729,98425,21619,62926,93836,79423,51314,7024,35015,8167,3377,7827,16121,29478,60183,94131,8936,9444,4429,20217,87627,50315,62321,88527,6336,0459,62514,3203,0057,63015,92710,88520,04523,29611,4378,89314,86410,05912,28514,6937001,0002,8001,0001,0007,2008,3009,2003,8004,8005,8006,8002,5002,1003,0003,900
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
53,851
66,434
59,847
53,879
36,444
42,139
26,191
12,372
8,450
6,962
5,958
5,978
4,391
4,193
18,313
17,340
20,648
23,615
15,565
9,229
5,286
4,205
6,847
11,202
17,672
26,712
36,373
38,025
23,917
13,597
2,907
48,599
143,617
135,721
112,685
147,554
152,042
137,548
301,642
276,967
180,335
91,126
115,331
111,515
68,321
50,996
30,358
78,636
70,612
21,980
2,484
0
0
0
57,474
77,902
169,860
157,649
2,250
0
0
0
0
0
0
0
0
0
0
0
000000000002,250157,649169,86077,90257,4740002,48421,98070,61278,63630,35850,99668,321111,515115,33191,126180,335276,967301,642137,548152,042147,554112,685135,721143,61748,5992,90713,59723,91738,02536,37326,71217,67211,2026,8474,2055,2869,22915,56523,61520,64817,34018,3134,1934,3915,9785,9586,9628,45012,37226,19142,13936,44453,87959,84766,43453,851000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
100
0
200
200
100
100
100
100
200
100
300
776
668
613
954
1,726
2,495
3,012
3,878
3,902
3,273
1,514
1,882
1,271
1,872
2,860
1,960
2,318
3,299
1,780
827
626
1,133
1,147
3,571
3,601
3,825
3,125
2,115
906
787
1,601
1,230
647
327
330
290
61
41
173
258
231
356
599
54
3,351
3,852
3,865
3,801
3,134
5,729
4,194
2,581
4,173
2,722
5,105
6,899
10,579
8,558
7,092
10,610
10,870
4,840
4,334
2,320
406
363
591
233
809
847
876
37,911
859
0
0
-70,323
0
0
0
7,500
7,500
0
16,181
262,012
102,193
71,363
109,961
454,993
478,156
194,533
111,645
82,375
112,849
394,890
123,657
297,240
297,240123,657394,890112,84982,375111,645194,533478,156454,993109,96171,363102,193262,01216,18107,5007,500000-70,3230085937,9118768478092335913634062,3204,3344,84010,87010,6107,0928,55810,5796,8995,1052,7224,1732,5814,1945,7293,1343,8013,8653,8523,3515459935623125817341612903303276471,2301,6017879062,1153,1253,8253,6013,5711,1471,1336268271,7803,2992,3181,9602,8601,8721,2711,8821,5143,2733,9023,8783,0122,4951,726954613668776300100200100100100100200200010000000
       Other Current Assets 
0
100
200
700
100
100
100
300
100
100
100
100
100
0
0
100
49
43
34
757
729
837
804
567
1,659
1,907
1,915
722
538
539
611
1,614
1,545
2,908
899
1,770
1,373
1,329
962
1,347
1,128
1,306
930
312
1,796
1,033
958
841
414
711
523
132
994
806
387
1,295
698
452
348
1,607
1,702
2,243
392
1,558
177
261
235
171
886
20
365
573
504
269
402
9,492
11,489
13,201
15,582
54,281
20,703
19,944
21,510
52,351
19,952
19,187
21,007
46,008
17,726
17,092
15,847
107,471
16,571
11,630
84,259
93,890
10,977
27,316
83,851
441,816
114,731
2,307,133
119,047
2,141,976
191,647
309,581
285,307
1,691,429
188,714
192,903
152,018
226,023
226,023152,018192,903188,7141,691,429285,307309,581191,6472,141,976119,0472,307,133114,731441,81683,85127,31610,97793,89084,25911,63016,571107,47115,84717,09217,72646,00821,00719,18719,95252,35121,51019,94420,70354,28115,58213,20111,4899,492402269504573365208861712352611771,5583922,2431,7021,6073484526981,2953878069941325237114148419581,0331,7963129301,3061,1281,3479621,3291,3731,7708992,9081,5451,6146115395387221,9151,9071,659567804837729757344349100001001001001001003001001001007002001000
   > Long-term Assets 
2,900
2,900
3,000
2,500
2,600
2,600
2,500
2,500
2,600
2,600
2,600
2,600
2,600
2,500
3,400
3,400
3,360
3,642
3,781
39,493
42,372
41,787
41,059
42,088
45,538
48,287
50,239
51,263
51,278
51,071
51,316
52,097
52,180
52,040
55,140
54,056
53,005
51,994
49,842
46,771
45,982
46,087
45,281
44,535
44,324
44,559
44,389
42,275
43,185
42,468
42,838
41,529
41,320
41,180
40,945
41,102
41,560
41,351
41,504
41,507
41,160
40,930
40,832
40,467
42,195
41,999
44,062
51,937
46,982
47,553
90,054
90,936
89,726
145,389
100,535
87,844
88,747
91,719
94,532
98,781
107,912
105,023
105,721
106,471
103,055
119,023
108,082
99,182
95,033
91,472
89,937
88,702
97,925
79,171
75,788
75,710
72,836
295,846
272,803
334,276
361,582
394,595
391,760
421,634
487,470
486,991
507,472
555,288
571,671
557,494
650,393
711,454
711,454650,393557,494571,671555,288507,472486,991487,470421,634391,760394,595361,582334,276272,803295,84672,83675,71075,78879,17197,92588,70289,93791,47295,03399,182108,082119,023103,055106,471105,721105,023107,91298,78194,53291,71988,74787,844100,535145,38989,72690,93690,05447,55346,98251,93744,06241,99942,19540,46740,83240,93041,16041,50741,50441,35141,56041,10240,94541,18041,32041,52942,83842,46843,18542,27544,38944,55944,32444,53545,28146,08745,98246,77149,84251,99453,00554,05655,14052,04052,18052,09751,31651,07151,27851,26350,23948,28745,53842,08841,05941,78742,37239,4933,7813,6423,3603,4003,4002,5002,6002,6002,6002,6002,6002,5002,5002,6002,6002,5003,0002,9002,900
       Property Plant Equipment 
1,300
1,300
1,300
1,000
1,000
900
900
900
1,000
1,000
1,000
1,000
1,000
1,000
1,100
1,100
1,142
1,450
1,549
1,927
2,182
2,457
2,513
4,326
7,939
10,852
12,968
13,655
13,858
13,840
14,275
15,244
15,347
15,117
14,568
14,147
13,447
12,759
12,116
11,589
11,103
10,761
10,237
9,861
9,710
9,555
9,381
5,721
7,874
7,940
8,365
8,228
8,019
7,879
7,644
7,801
8,259
8,050
8,203
8,206
7,859
7,629
7,531
6,857
7,949
7,753
9,815
11,456
11,617
13,320
13,969
14,251
14,270
15,124
17,492
19,737
23,967
26,134
29,421
32,342
36,558
39,668
40,955
40,184
39,439
38,531
37,299
35,987
32,422
30,829
29,343
28,426
26,972
12,987
12,244
11,445
10,795
115,375
131,834
179,954
192,044
213,186
214,751
228,696
333,565
340,296
364,075
400,488
411,337
395,694
491,723
490,989
490,989491,723395,694411,337400,488364,075340,296333,565228,696214,751213,186192,044179,954131,834115,37510,79511,44512,24412,98726,97228,42629,34330,82932,42235,98737,29938,53139,43940,18440,95539,66836,55832,34229,42126,13423,96719,73717,49215,12414,27014,25113,96913,32011,61711,4569,8157,7537,9496,8577,5317,6297,8598,2068,2038,0508,2597,8017,6447,8798,0198,2288,3657,9407,8745,7219,3819,5559,7109,86110,23710,76111,10311,58912,11612,75913,44714,14714,56815,11715,34715,24414,27513,84013,85813,65512,96810,8527,9394,3262,5132,4572,1821,9271,5491,4501,1421,1001,1001,0001,0001,0001,0001,0001,0009009009001,0001,0001,3001,3001,300
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
58,759
59,519
58,621
57,906
56,174
54,612
52,664
53,307
53,062
53,065
53,766
52,941
52,694
51,673
51,941
52,991
53,746
53,563
53,286
51,983
52,072
51,967
51,245
51,280
50,305
51,154
49,988
118,849
126,932
135,379
130,879
134,294
131,989
131,479
130,756
123,467
117,535
126,331
129,827
128,366
123,780
127,454
127,454123,780128,366129,827126,331117,535123,467130,756131,479131,989134,294130,879135,379126,932118,84949,98851,15450,30551,28051,24551,96752,07251,98353,28653,56353,74652,99151,94151,67352,69452,94153,76653,06553,06253,30752,66454,61256,17457,90658,62159,51958,75933,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,141000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
56,352
12,189
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000012,18956,3520000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
1,400
0
0
0
1,500
1,600
1,500
0
1,600
1,600
0
1,600
1,600
1,600
2,300
1,600
1,604
1,613
1,603
37,566
40,190
39,330
38,546
37,762
37,599
37,435
37,271
37,107
36,944
36,778
36,615
36,451
36,287
36,124
38,608
38,189
37,973
37,758
36,471
34,251
1,077
1,044
1,011
978
945
912
879
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
33,141
16,405
16,250
15,918
15,090
13,763
12,577
11,198
11,360
11,005
10,793
10,962
10,300
9,958
9,225
9,161
9,475
8,138
7,873
7,575
6,897
6,754
6,541
6,114
5,958
5,469
5,581
5,052
5,250
5,332
5,725
5,270
5,281
5,027
4,770
4,535
4,033
8,456
0
0
0
0
0
000008,4564,0334,5354,7705,0275,2815,2705,7255,3325,2505,0525,5815,4695,9586,1146,5416,7546,8977,5757,8738,1389,4759,1619,2259,95810,30010,96210,79311,00511,36011,19812,57713,76315,09015,91816,25016,40533,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,14133,1418799129459781,0111,0441,07734,25136,47137,75837,97338,18938,60836,12436,28736,45136,61536,77836,94437,10737,27137,43537,59937,76238,54639,33040,19037,5661,6031,6131,6041,6002,3001,6001,6001,60001,6001,60001,5001,6001,5000001,400
       Long-term Assets Other 
200
1,600
1,700
1,500
100
100
100
1,600
1,600
0
1,600
0
0
-100
0
700
614
579
629
0
0
0
0
0
0
0
0
501
476
453
426
402
546
799
1,964
1,720
1,585
1,477
1,255
931
661
1,141
892
555
528
951
988
3,413
2,170
1,387
1,332
160
160
160
160
160
160
160
160
160
160
160
160
469
1,105
1,105
1,106
1,107
1,107
1,092
921
916
917
917
917
918
918
918
1,044
2,581
6,626
2,114
2,114
5,389
2,514
18,026
8,899
1,759
1,750
1,763
1,768
1,768
13,594
8,946
7,770
7,530
7,001
56,372
8,705
13,218
33,389
41,834
39,993
56,689
18,614
19,195
17,406
28,469
30,507
33,434
34,890
30,278
30,27834,89033,43430,50728,46917,40619,19518,61456,68939,99341,83433,38913,2188,70556,3727,0017,5307,7708,94613,5941,7681,7681,7631,7501,7598,89918,0262,5145,3892,1142,1146,6262,5811,0449189189189179179179169211,0921,1071,1071,1061,1051,1054691601601601601601601601601601601601601,3321,3872,1703,4139889515285558921,1416619311,2551,4771,5851,7201,964799546402426453476501000000006295796147000-100001,60001,6001,6001001001001,5001,7001,600200
> Total Liabilities 
500
500
400
600
400
500
200
300
300
300
200
800
800
300
1,000
1,700
1,406
1,714
2,027
24,705
24,057
28,103
38,833
39,622
39,861
50,274
49,193
49,432
48,341
47,786
48,732
48,215
48,050
51,279
44,058
44,712
42,183
41,604
40,644
34,730
26,327
26,746
26,242
27,876
28,278
27,780
27,823
28,226
30,426
33,556
33,387
31,136
30,168
13,500
8,863
11,140
12,238
11,422
12,321
15,794
16,607
13,075
12,488
12,727
14,313
15,898
19,170
22,105
21,136
23,692
28,500
32,703
27,539
30,260
30,864
46,384
39,135
37,095
37,618
93,369
407,074
414,887
409,842
399,847
390,603
414,768
408,228
404,225
375,436
373,514
377,157
375,913
371,902
374,882
354,648
358,974
352,039
747,701
837,580
955,270
1,569,239
2,004,025
2,104,605
2,928,426
2,769,551
3,039,943
2,833,422
2,892,757
2,438,281
2,439,567
2,335,507
2,572,269
2,572,2692,335,5072,439,5672,438,2812,892,7572,833,4223,039,9432,769,5512,928,4262,104,6052,004,0251,569,239955,270837,580747,701352,039358,974354,648374,882371,902375,913377,157373,514375,436404,225408,228414,768390,603399,847409,842414,887407,07493,36937,61837,09539,13546,38430,86430,26027,53932,70328,50023,69221,13622,10519,17015,89814,31312,72712,48813,07516,60715,79412,32111,42212,23811,1408,86313,50030,16831,13633,38733,55630,42628,22627,82327,78028,27827,87626,24226,74626,32734,73040,64441,60442,18344,71244,05851,27948,05048,21548,73247,78648,34149,43249,19350,27439,86139,62238,83328,10324,05724,7052,0271,7141,4061,7001,000300800800200300300300200500400600400500500
   > Total Current Liabilities 
500
500
400
600
400
400
200
300
300
300
200
900
900
300
900
900
1,406
1,714
2,027
4,705
4,057
5,353
6,145
6,997
7,298
7,774
6,756
5,864
4,594
4,191
5,249
4,836
4,777
8,111
7,845
8,576
6,130
5,631
4,708
4,876
3,543
4,033
3,616
5,339
5,674
5,645
5,617
6,206
8,325
9,029
30,185
27,717
26,832
10,192
5,647
8,027
9,233
8,523
9,528
10,266
11,126
8,995
6,741
7,579
7,841
9,422
10,441
11,675
9,253
11,256
14,260
18,934
13,715
17,479
18,635
34,116
28,776
27,053
24,873
76,494
71,051
81,878
75,684
66,406
56,498
66,791
68,277
73,675
44,904
43,019
46,715
45,539
31,496
41,488
21,575
25,795
18,982
213,331
239,218
322,035
1,208,555
1,651,516
1,753,415
2,390,319
2,261,005
2,156,239
1,667,961
2,459,944
1,918,858
1,596,255
1,468,590
1,635,138
1,635,1381,468,5901,596,2551,918,8582,459,9441,667,9612,156,2392,261,0052,390,3191,753,4151,651,5161,208,555322,035239,218213,33118,98225,79521,57541,48831,49645,53946,71543,01944,90473,67568,27766,79156,49866,40675,68481,87871,05176,49424,87327,05328,77634,11618,63517,47913,71518,93414,26011,2569,25311,67510,4419,4227,8417,5796,7418,99511,12610,2669,5288,5239,2338,0275,64710,19226,83227,71730,1859,0298,3256,2065,6175,6455,6745,3393,6164,0333,5434,8764,7085,6316,1308,5767,8458,1114,7774,8365,2494,1914,5945,8646,7567,7747,2986,9976,1455,3534,0574,7052,0271,7141,406900900300900900200300300300200400400600400500500
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200
100
74
37
0
0
0
0
0
4,337
4,337
0
0
211
169
226
226
1,065
782
435
357
1,194
932
654
467
853
552
386
219
731
1,298
650
788
1,120
1,061
333
21,858
22,428
22,266
5,230
281
80
80
80
80
80
80
60
40
20
7
0
214
215
449
631
712
985
957
919
884
603
579
532
493
395
252
149
45
29,586
26,681
27,383
30,181
34,688
21,256
27,120
22,994
24,628
3,491
18,985
1,191
1,262
12,035
43,768
55,860
322,035
121,144
98,383
103,987
130,533
440,498
448,429
406,620
352,077
1,205
953
1,332
28,119
28,1191,3329531,205352,077406,620448,429440,498130,533103,98798,383121,144322,03555,86043,76812,0351,2621,19118,9853,49124,62822,99427,12021,25634,68830,18127,38326,68129,58645149252395493532579603884919957985712631449215214072040608080808080802815,23022,26622,42821,8583331,0611,1207886501,2987312193865528534676549321,1943574357821,065226226169211004,3374,33700000377410020000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
603
0
0
0
395
252
149
45
316,339
316,695
317,051
317,407
317,763
318,119
318,475
0
0
3,491
0
0
0
0
0
0
322,035
0
0
0
0
323,814
324,169
324,525
324,881
0
0
0
0
0000324,881324,525324,169323,8140000322,0350000003,49100318,475318,119317,763317,407317,051316,695316,33945149252395000603000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
400
400
300
400
300
300
100
200
200
200
100
800
800
200
700
600
614
1,311
1,925
1,401
1,048
1,521
1,483
1,410
1,826
4,318
2,584
2,534
1,599
1,694
2,201
2,342
2,364
4,058
4,114
3,242
1,518
1,230
753
1,426
811
780
884
1,530
1,764
2,479
2,359
1,490
2,186
729
1,967
1,750
1,024
1,460
1,544
2,098
5,474
3,433
3,350
3,572
3,362
2,961
2,395
2,645
2,959
3,380
2,203
3,228
2,173
2,946
3,339
5,985
4,018
4,495
2,975
12,908
9,742
7,117
8,201
11,889
11,237
15,991
16,231
5,685
3,790
8,021
5,242
5,613
5,770
6,686
6,790
9,301
6,150
4,303
4,210
2,910
2,518
9,242
15,097
54,332
113,605
73,995
59,564
127,050
135,128
386,488
144,997
216,517
124,801
87,246
101,914
132,610
132,610101,91487,246124,801216,517144,997386,488135,128127,05059,56473,995113,60554,33215,0979,2422,5182,9104,2104,3036,1509,3016,7906,6865,7705,6135,2428,0213,7905,68516,23115,99111,23711,8898,2017,1179,74212,9082,9754,4954,0185,9853,3392,9462,1733,2282,2033,3802,9592,6452,3952,9613,3623,5723,3503,4335,4742,0981,5441,4601,0241,7501,9677292,1861,4902,3592,4791,7641,5308847808111,4267531,2301,5183,2424,1144,0582,3642,3422,2011,6941,5992,5342,5844,3181,8261,4101,4831,5211,0481,4011,9251,311614600700200800800100200200200100300300400300400400
       Other Current Liabilities 
100
100
100
200
100
100
100
100
100
100
100
100
100
100
0
200
718
366
102
3,304
3,009
3,832
2,662
5,587
4,972
3,031
3,822
2,844
2,576
2,021
2,572
1,179
1,381
3,368
3,374
4,140
3,680
3,747
3,488
2,597
96
54
13
3,078
2,612
2,516
2,470
616
2,839
4,277
399
242
3,542
3,229
3,822
5,417
3,618
4,956
6,091
6,614
5,184
3,110
3,931
4,528
4,478
5,633
6,800
7,974
6,553
5,179
10,019
11,693
8,683
12,040
14,773
18,105
15,955
16,904
13,679
29,741
30,655
32,931
29,251
1,056
1,348
1,359
1,390
7,749
1,501
1,530
1,566
1,600
15,912
14,012
13,584
19,945
1,316
1,470
86,447
-327,560
150,997
259,065
327,504
709,792
591,147
619,804
711,568
1,521,213
1,377,088
1,207,583
1,173,157
1,233,099
1,233,0991,173,1571,207,5831,377,0881,521,213711,568619,804591,147709,792327,504259,065150,997-327,56086,4471,4701,31619,94513,58414,01215,9121,6001,5661,5301,5017,7491,3901,3591,3481,05629,25132,93130,65529,74113,67916,90415,95518,10514,77312,0408,68311,69310,0195,1796,5537,9746,8005,6334,4784,5283,9313,1105,1846,6146,0914,9563,6185,4173,8223,2293,5422423994,2772,8396162,4702,5162,6123,0781354962,5973,4883,7473,6804,1403,3743,3681,3811,1792,5722,0212,5762,8443,8223,0314,9725,5872,6623,8323,0093,3041023667182000100100100100100100100100100100200100100100
   > Long-term Liabilities 
0
0
0
0
0
100
0
0
0
0
0
-100
-100
0
100
800
600
200
0
20,000
20,000
22,750
32,688
32,625
32,563
42,500
42,437
43,568
43,747
43,595
43,483
43,379
43,273
43,168
36,213
36,136
36,053
35,973
35,936
29,854
22,784
22,713
22,626
22,537
22,604
22,135
22,206
22,020
22,101
24,527
3,202
3,419
3,336
3,308
3,216
3,113
3,005
2,899
2,793
5,528
5,481
4,080
5,747
5,148
6,472
6,476
8,729
10,430
11,883
12,436
14,240
13,769
13,824
12,781
12,229
12,268
10,359
10,042
12,745
16,875
336,023
333,009
334,158
333,441
334,105
347,977
339,951
330,550
330,532
330,495
330,442
330,374
340,406
333,394
333,073
333,179
333,057
534,370
598,362
633,235
360,684
352,509
351,190
538,107
508,546
883,704
1,165,461
432,813
519,423
843,312
866,917
937,131
937,131866,917843,312519,423432,8131,165,461883,704508,546538,107351,190352,509360,684633,235598,362534,370333,057333,179333,073333,394340,406330,374330,442330,495330,532330,550339,951347,977334,105333,441334,158333,009336,02316,87512,74510,04210,35912,26812,22912,78113,82413,76914,24012,43611,88310,4308,7296,4766,4725,1485,7474,0805,4815,5282,7932,8993,0053,1133,2163,3083,3363,4193,20224,52722,10122,02022,20622,13522,60422,53722,62622,71322,78429,85435,93635,97336,05336,13636,21343,16843,27343,37943,48343,59543,74743,56842,43742,50032,56332,62532,68822,75020,00020,00002006008001000-100-1000000010000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300
300
300
400
400
1,045
990
1,512
1,859
1,875
1,199
1,052
889
721
0
0
0
0
0
0
0
0
0
0
0
0
0
0
318,475
318,830
319,187
319,543
319,899
320,255
320,611
320,967
321,323
321,679
322,035
0
0
0
323,458
0
0
0
0
0
0
0
0
00000000323,458000322,035321,679321,323320,967320,611320,255319,899319,543319,187318,830318,475000000000000007218891,0521,1991,8751,8591,5129901,0454004003003003000000000000000000000000000000000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
199,822
199,822
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000199,822199,8220000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,750
2,688
2,625
2,563
2,500
2,437
2,466
2,313
2,250
2,187
2,279
2,224
2,171
166
244
166
165
190
176
160
144
112
79
208
360
389
391
390
2,733
3,002
2,939
2,868
2,858
3,216
2,707
2,625
2,539
2,453
5,208
5,181
3,780
5,447
4,848
6,072
6,076
7,684
9,440
10,371
10,577
12,365
12,570
12,772
11,892
11,508
11,765
10,107
9,893
12,700
16,838
20,752
17,382
18,175
17,102
17,410
30,926
22,544
12,787
12,413
12,020
11,612
11,187
3,467
2,811
2,568
2,564
2,500
2,500
2,500
3,358
0
0
0
175,533
441,748
814,629
1,035,418
185,024
0
606,937
608,842
0
0608,842606,9370185,0241,035,418814,629441,748175,5330003,3582,5002,5002,5002,5642,5682,8113,46711,18711,61212,02012,41312,78722,54430,92617,41017,10218,17517,38220,75216,83812,7009,89310,10711,76511,50811,89212,77212,57012,36510,57710,3719,4407,6846,0766,0724,8485,4473,7805,1815,2082,4532,5392,6252,7073,2162,8582,8682,9393,0022,733390391389360208791121441601761901651662441662,1712,2242,2792,1872,2502,3132,4662,4372,5002,5632,6252,6882,750000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,780
5,447
4,848
6,072
6,076
7,684
9,440
10,371
10,577
10,787
11,002
11,210
10,385
10,109
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,500
2,500
2,500
3,399
2,743
2,500
2,500
2,500
2,500
2,500
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000002,5002,5002,5002,5002,5002,7433,3992,5002,5002,5000000000000000010,10910,38511,21011,00210,78710,57710,3719,4407,6846,0766,0724,8485,4473,7800000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
6,300
5,500
4,900
5,100
9,100
8,100
7,200
6,500
11,800
10,800
9,800
3,000
3,000
5,200
3,500
2,800
17,472
14,924
12,460
31,824
30,275
29,278
29,997
27,493
23,029
19,775
13,035
8,073
19,696
16,122
12,831
35,944
30,750
23,338
43,542
33,281
24,395
18,694
19,902
49,652
109,105
103,830
99,139
94,001
87,112
80,259
71,883
63,065
55,795
47,221
56,132
45,489
37,794
59,721
67,017
74,465
63,139
57,523
66,993
59,050
53,529
56,271
54,597
53,849
54,324
61,079
61,376
80,240
77,568
69,226
216,574
203,234
191,060
281,731
261,650
229,618
399,706
387,603
367,016
292,669
185,433
110,117
49,784
-5,546
-29,099
-59,062
-74,151
-101,732
-99,369
-87,707
-126,679
-167,935
-150,583
-185,493
-189,838
-186,017
-23,971
184,526
106,440
627,209
1,039,127
745,562
461,336
-351,673
65,324
-416,950
-565,985
-634,078
-895,582
-754,519
-678,350
-716,927
-716,927-678,350-754,519-895,582-634,078-565,985-416,95065,324-351,673461,336745,5621,039,127627,209106,440184,526-23,971-186,017-189,838-185,493-150,583-167,935-126,679-87,707-99,369-101,732-74,151-59,062-29,099-5,54649,784110,117185,433292,669367,016387,603399,706229,618261,650281,731191,060203,234216,57469,22677,56880,24061,37661,07954,32453,84954,59756,27153,52959,05066,99357,52363,13974,46567,01759,72137,79445,48956,13247,22155,79563,06571,88380,25987,11294,00199,139103,830109,10549,65219,90218,69424,39533,28143,54223,33830,75035,94412,83116,12219,6968,07313,03519,77523,02927,49329,99729,27830,27531,82412,46014,92417,4722,8003,5005,2003,0003,0009,80010,80011,8006,5007,2008,1009,1005,1004,9005,5006,300
   Common Stock
0
0
0
0
0
0
0
0
0
-6,000
-6,000
0
0
200
200
200
198
199
200
226
229
230
238
239
249
252
252
252
299
303
304
349
350
351
398
398
398
398
441
503
617
618
618
622
623
624
624
624
624
624
692
692
693
892
938
1,007
1,008
1,023
1,111
1,115
1,120
1,151
1,154
1,175
1,226
1,326
1,360
1,484
1,517
1,532
2,090
2,091
2,097
2,386
2,389
2,393
2,684
2,691
2,703
2,704
2,712
2,714
2,717
2,717
2,831
2,904
3,106
3,237
3,472
3,821
3,832
3,849
4,699
235
256
324
539
612
633
714
745
747
760
764
787
788
792
868
871
952
1,196
1,405
1,4051,1969528718687927887877647607477457146336125393242562354,6993,8493,8323,8213,4723,2373,1062,9042,8312,7172,7172,7142,7122,7042,7032,6912,6842,3932,3892,3862,0972,0912,0901,5321,5171,4841,3601,3261,2261,1751,1541,1511,1201,1151,1111,0231,0081,00793889269369269262462462462462462362261861861750344139839839839835135034930430329925225225224923923823022922620019919820020020000-6,000-6,000000000000
   Retained Earnings -4,820,951-4,642,562-4,511,786-4,569,794-4,275,889-4,093,640-3,925,027-3,414,542-3,617,950-2,771,666-2,449,235-2,096,918-1,874,199-1,696,635-1,499,325-1,457,665-1,431,801-1,399,971-1,381,928-1,342,325-1,299,107-1,249,773-1,205,203-1,160,711-1,114,359-1,063,517-1,018,909-974,444-929,996-872,887-806,633-727,282-650,030-571,224-538,104-517,463-493,093-461,547-441,820-423,956-410,146-396,092-380,793-368,159-358,163-350,128-342,912-336,992-329,656-325,951-322,738-317,745-310,292-305,344-294,988-285,562-274,150-260,195-252,665-244,125-235,776-224,696-216,854-207,482-199,727-190,510-181,544-173,350-164,962-158,814-153,800-147,389-141,894-148,049-145,322-139,606-130,720-120,431-117,775-110,058-104,800-101,717-98,357-93,328-87,527-82,382-75,668-70,172-64,830-61,637-59,125-57,317-55,085-50,098-46,885-44,244-42,900-41,900-40,200-38,400-38,400-34,500-33,300-32,200-31,300-30,300-29,100-28,000-26,800-24,900-23,900-22,500
   Accumulated Other Comprehensive Income 
-800
-800
-900
-400
-400
-500
-500
-500
-600
-600
-600
-700
-700
-800
-800
-700
-3
-3
-1
-1,103
-1,103
-1,103
-1,103
-1,223
-1,480
-1,223
-1,519
-1,480
-1,480
-1,480
-1,480
-1,480
-1,480
-1,480
-1,480
-1,480
-1,480
-1,480
-1,480
-1,905
-1,480
-1,032
-1,032
-1,031
-9,684
-10,381
-11,072
-8,109
-8,337
-9,210
-1,572
-2,022
-2,098
479
650
820
758
734
864
772
899
910
913
832
976
940
1,036
430
469
637
1,113
839
90
-1,293
-4,111
-6,605
-9,756
-8,710
-9,068
-9,124
-7,548
-9,143
-9,804
-11,814
-11,335
-9,603
-8,304
-8,617
-9,071
-11,173
-11,026
-11,191
-12,360
-12,290
-13,854
-12,508
-14,486
-13,195
-4,995
7,024
-357
4,170
861
-1,353
-1,312
-10,870
-23,794
-6,377
-3,166
-8,177
-11,863
2,722
2,722-11,863-8,177-3,166-6,377-23,794-10,870-1,312-1,3538614,170-3577,024-4,995-13,195-14,486-12,508-13,854-12,290-12,360-11,191-11,026-11,173-9,071-8,617-8,304-9,603-11,335-11,814-9,804-9,143-7,548-9,124-9,068-8,710-9,756-6,605-4,111-1,293908391,1136374694301,036940976832913910899772864734758820650479-2,098-2,022-1,572-9,210-8,337-8,109-11,072-10,381-9,684-1,031-1,032-1,032-1,480-1,905-1,480-1,480-1,480-1,480-1,480-1,480-1,480-1,480-1,480-1,480-1,480-1,480-1,519-1,223-1,480-1,223-1,103-1,103-1,103-1,103-1-3-3-700-800-800-700-700-600-600-600-500-500-500-400-400-900-800-800
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
380,970
380,931
383,948
391,564
404,175
411,558
438,939
446,191
450,300
611,913
612,900
615,279
724,908
727,369
729,373
926,691
934,176
947,055
951,569
920,001
925,629
932,208
935,997
956,299
968,996
997,014
1,020,457
1,069,391
1,127,298
1,132,738
1,140,964
1,201,853
1,210,941
1,226,314
1,260,551
1,450,279
1,699,072
1,848,644
2,535,476
3,180,114
3,237,085
3,310,513
3,351,967
3,566,292
3,604,614
3,640,597
0
3,767,733
3,855,916
0
0
003,855,9163,767,73303,640,5973,604,6143,566,2923,351,9673,310,5133,237,0853,180,1142,535,4761,848,6441,699,0721,450,2791,260,5511,226,3141,210,9411,201,8531,140,9641,132,7381,127,2981,069,3911,020,457997,014968,996956,299935,997932,208925,629920,001951,569947,055934,176926,691729,373727,369724,908615,279612,900611,913450,300446,191438,939411,558404,175391,564383,948380,931380,9700000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000-89,940-86,455-85,901-85,101-79,132-47,205-44,457-41,806-41,207-2,638-2,638-2,583-2,583-2,451-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,450-2,449-2,356-2,356-2,413-2,413-2,413-2,413-2,413-2,413-2,413-2,413-2,413-4,733-4,733-4,733-5,533-5,533-5,546-5,777-5,777-5,690-5,690-5,690-4,928-4,835-4,835-4,8350000000000000000
   Other Stockholders Equity 
29,600
30,200
30,700
32,300
37,500
37,700
38,000
38,300
44,600
44,700
44,900
42,100
42,100
46,000
46,000
46,200
62,218
62,569
63,360
87,786
87,363
89,276
92,499
93,307
94,175
96,414
96,388
97,055
114,432
115,883
115,951
142,520
143,067
143,917
166,794
167,455
168,163
168,885
173,443
197,250
262,797
264,608
265,667
267,317
269,523
271,560
272,841
270,277
270,990
272,661
282,707
282,595
283,324
313,897
325,274
346,608
346,693
350,488
370,226
367,227
369,154
376,858
378,394
381,330
389,090
401,665
409,144
444,073
444,210
447,487
609,576
610,289
612,919
722,165
724,808
727,318
924,485
932,016
944,537
948,995
918,003
923,036
929,954
933,733
953,514
966,943
994,260
1,018,390
1,066,870
1,124,675
1,130,262
1,138,323
1,199,043
1,208,200
1,223,877
1,258,460
1,447,155
1,496,612
1,607,615
2,493,670
3,135,657
3,189,880
3,231,381
3,266,866
3,480,391
3,518,159
3,550,657
3,647,320
3,676,507
3,764,492
3,974,879
4,099,897
4,099,8973,974,8793,764,4923,676,5073,647,3203,550,6573,518,1593,480,3913,266,8663,231,3813,189,8803,135,6572,493,6701,607,6151,496,6121,447,1551,258,4601,223,8771,208,2001,199,0431,138,3231,130,2621,124,6751,066,8701,018,390994,260966,943953,514933,733929,954923,036918,003948,995944,537932,016924,485727,318724,808722,165612,919610,289609,576447,487444,210444,073409,144401,665389,090381,330378,394376,858369,154367,227370,226350,488346,693346,608325,274313,897283,324282,595282,707272,661270,990270,277272,841271,560269,523267,317265,667264,608262,797197,250173,443168,885168,163167,455166,794143,917143,067142,520115,951115,883114,43297,05596,38896,41494,17593,30792,49989,27687,36387,78663,36062,56962,21846,20046,00046,00042,10042,10044,90044,70044,60038,30038,00037,70037,50032,30030,70030,20029,600



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue983,705
Cost of Revenue-279,468
Gross Profit704,237704,237
 
Operating Income (+$)
Gross Profit704,237
Operating Expense-1,119,264
Operating Income-415,027-415,027
 
Operating Expense (+$)
Research Development656,002
Selling General Administrative475,372
Selling And Marketing Expenses0
Operating Expense1,119,2641,131,374
 
Net Interest Income (+$)
Interest Income0
Interest Expense-14,416
Other Finance Cost-484
Net Interest Income-14,900
 
Pretax Income (+$)
Operating Income-415,027
Net Interest Income-14,900
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-543,031-287,023
EBIT - interestExpense = -429,443
-543,031
-530,646
Interest Expense14,416
Earnings Before Interest and Taxes (EBIT)-415,027-528,615
Earnings Before Interest and Taxes (EBITDA)-373,802
 
After tax Income (+$)
Income Before Tax-543,031
Tax Provision--1,917
Net Income From Continuing Ops-548,922-541,114
Net Income-545,062
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,398,732
Total Other Income/Expenses Net-128,00414,900
 

Technical Analysis of Novavax
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Novavax. The general trend of Novavax is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Novavax's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Novavax Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6 < 6.05 < 6.05.

The bearish price targets are: 3.5324.

Tweet this
Novavax Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Novavax Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Novavax Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Novavax Inc. The current macd is -0.23482352.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Novavax price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Novavax. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Novavax price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Novavax Inc Daily Moving Average Convergence/Divergence (MACD) ChartNovavax Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Novavax Inc. The current adx is 10.60.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Novavax shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Novavax Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Novavax Inc. The current sar is 4.50717609.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Novavax Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Novavax Inc. The current rsi is 30.15. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Novavax Inc Daily Relative Strength Index (RSI) ChartNovavax Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Novavax Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Novavax price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Novavax Inc Daily Stochastic Oscillator ChartNovavax Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Novavax Inc. The current cci is -159.52723269.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Novavax Inc Daily Commodity Channel Index (CCI) ChartNovavax Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Novavax Inc. The current cmo is -62.01345447.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Novavax Inc Daily Chande Momentum Oscillator (CMO) ChartNovavax Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Novavax Inc. The current willr is -92.30769231.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Novavax Inc Daily Williams %R ChartNovavax Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Novavax Inc.

Novavax Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Novavax Inc. The current atr is 0.26308251.

Novavax Inc Daily Average True Range (ATR) ChartNovavax Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Novavax Inc. The current obv is -137,943,667.

Novavax Inc Daily On-Balance Volume (OBV) ChartNovavax Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Novavax Inc. The current mfi is 28.30.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Novavax Inc Daily Money Flow Index (MFI) ChartNovavax Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Novavax Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Novavax Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Novavax Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.153
Ma 20Greater thanMa 504.437
Ma 50Greater thanMa 1004.677
Ma 100Greater thanMa 2004.768
OpenGreater thanClose3.890
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Novavax with someone you think should read this too:
  • Are you bullish or bearish on Novavax? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Novavax? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Novavax Inc

I send you an email if I find something interesting about Novavax Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Novavax Inc.

Receive notifications about Novavax Inc in your mailbox!